Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Account Payables (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Change in Account Payables for 2 consecutive years, with $344000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 157.14% to $344000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.9 million, a N/A change, with the full-year FY2024 number at $1.2 million, up 134.22% from a year prior.
  • Change in Account Payables was $344000.0 for Q3 2025 at Pyxis Oncology, down from $6.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.6 million in Q2 2025 to a low of -$2.0 million in Q1 2025.